Straumann Holding AG / Keyword(s): Miscellaneous/Corporate strategic decision
Straumann Group Announces Appointment of New Executive Board Members to Support Growth Strategy
01.04.2022 / 07:00
Basel, April 1, 2022: Today, the Straumann Group announced changes to the Executive Management Board (EMB) that will ensure its leadership team structure reflects and supports the group’s growth strategy. These announcements follow the evolved Strategy Compass that was introduced in December 2021.
Jason Forbes will join the new Chief Consumer Officer on April 19, 2022
Patients become consumers of health – educate themselves, demand more, and take ownership of health care decisions. To respond to this trend, building a presence with consumers is part of the Group’s strategic compass, which is at the origin of this new EMB positioning. Jason will lead direct-to-consumer companies such as DrSmile, Smilink and Nihon Implant, as well as all Straumann Group direct-to-patient strategic initiatives.
Jason joins the Straumann Group from Hilding Anders, a global mattress and sleep company, where he was President, Online Brands and Group Chief Digital Officer. There, he successfully developed a new set of consumer-centric capabilities, launched their direct-to-consumer (DTC) brands during the Covid-19 pandemic, and was instrumental in driving digital transformation across the marketing, product innovation and supply chain. Previously, Jason worked for beauty company Coty, where, in his capacity as Global Chief Digital and Media Officer, he led their global digital transformation. Jason joined Coty through the acquisition of Beamly, an award-winning MarTech company of which Jason was CEO. Jason has worked across multiple industries, from media to beverage to retail, but with commonalities to drive digital capacity building and business impact, both in DTC and B2B. Jason holds an MBA from IMD in Lausanne, an MSc and BBS in International Business and Economics from Trinity College Dublin, and certificates from INSEAD and Harvard Business School.
Sébastien Roche appointed Head COO from April 1
Sébastien Roche joins the Straumann Group as the new Director of Operations and Supply Chain (COO), an expanded role. He is based in Basel at the headquarters and is a member of the EMB. Sébastien has extensive experience in the pharmaceutical and manufacturing industries, having joined TEVA, the pharmaceutical company, where he most recently served as Senior Vice President and was responsible for up to 28 manufacturing sites in the United States, Americas Latin, Europe and Asia. Sébastien will oversee the Straumann Group production sites which will include all SDIS and biomaterials manufacturing sites. The manufacture of competing brands Anthogyr, Medentika and Neodent will be closely linked in the future. Born in 1972, Sébastien Roche is French and holds a master’s degree in Aeronautics and Space from the Institut Supérieur de l’Aéronautique et de l’Espace in Toulouse, France.
Guillaume Daniellot, Chief Executive Officer, said: “These leadership changes aim to ensure that we are well positioned to achieve our strategic ambitions. Major trends are reflected in our strategic compass and by welcoming Jason Forbes, the “construction consumer presence” will be represented in our EMB structure. Sébastien Roche’s extensive experience in the pharmaceutical and manufacturing industries will also be of great value to the Straumann Group. We are very happy to welcome Sébastien and Jason who will complete the team with their skills, their talent and their passion for culture. I wish them both a warm welcome.
Mark Johnson will pursue opportunities outside the company
Mark Johnson has served as Executive Vice President, Head of Operations, Regulatory Affairs and Quality since 2020. He is leaving the Straumann Group after leading the team through the demanding pandemic period. The company thanks Mark for his contributions and wishes him the best for the future.
About the Straumann Group
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It brings together global and international brands that are synonymous with excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other companies and fully/partially owned partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prostheses, orthodontic aligners, biomaterials and digital solutions for correction, replacement and restoration of teeth or to prevent tooth loss.
Based in Basel, Switzerland, the group currently employs over 9,000 people worldwide. Its products, solutions and services are available in more than 100 countries through a large network of distribution subsidiaries and partners.
Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland
Telephone: +41 (0)61 965 11 11
This release contains forward-looking statements that reflect management’s current beliefs and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Straumann Group to differ materially. of those expressed or implied. in this document. Statements are made based on management’s beliefs and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties, including, but not limited to, future global economic conditions, pandemics, currency exchange rates, legal provisions, market conditions, competitor activities and others. factors beyond Straumann’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those forecast or expected. Straumann is providing the information in this release as of this date and assumes no obligation to update any statements contained herein as a result of new information, future events or otherwise. This press release does not constitute an offer to sell or a solicitation to buy securities.
End of press release
|Company:||Straumann Holding AG|
|Peter Merianstraat 12|
|Fax:||+41 61 965 11 06|
|Listed:||SIX Swiss Stock Exchange|
|EQS news ID:||1317491|
|End of news||EQS News Service|
Trends in technical analysis STRAUMANN HOLDING AG
|Short term||Middle term||Long term|
Evolution of the income statement
|Number of analysts||15|
|Last closing price||CHF1,486.50|
|Average target price||CHF1,730.60|
|Average Spread / Target||16.4%|